Clinical Trial Update: A Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCT [NA]

View source ↗

Summary

This ClinicalTrials.gov entry describes a study evaluating the efficacy and safety of iNK cells for chronic active Epstein-Barr virus infection (CAEBV) and EBV-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Active Epstein-barr Virus Infection
• Hemophagocytic Lymphohistiocytosis

Drugs mentioned

• iNK Cells (induced natural killer cells)

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: CAEBV (Chronic Active Epstein-Barr Virus Infection) Syndrome, EBV | NA | Status: NOT_YET_RECRUITING